Skip to main content

Table 1 Comparison of basic data and clinical manifestations of patients in the three groups

From: Identification of risk factors for disseminated cryptococcosis in non-hiv patients: a retrospective analysis

Variables

PC group (n = 57)

CM group (n = 22)

DC group (n = 27)

χ2/F

P

Age(mean ± SD)

56.89 ± 13.36

57.36 ± 11.81

51.26 ± 12.80

2.016

0.138

Gender(male)

39(68.4)

15(68.2)

17(63.0)

0.256

0876

Underlying disease

 Hypertension

19(33.4)

5(22.7)

12(44.4)

2.571

0.277

 Diabetes mellitus

10(17.5)

1(4.5)

9(33.3)

6.704

0.035

 Renal failure

1(1.8)

3(13.6)

1(3.7)

4.274

0.056

 Malignant tumor

2(3.5)

1(4.5)

2(7.4)

0.976

0.828

 Chronic lung disease

2(3.5)

1(4.5)

3(11.1)

2.048

0.400

 Decompensation of cirrhosis

11(19.3)

1(4.5)

9(33.3)

6.344

0.042

 Glucocorticoid

4(7.0)

5(22.7)

4(14.8)

3.952

0.135

 Immunosuppressant

6(10.5)

2(9.1)

9(33.3)

6.985

0.028

Clinical manifestation

 Fever

15(26.3)

4(18.2)

10(37.0)

2.236

0.327

 Cough

25(43.9)

4(18.2)

11(40.7)

4.594

0.101

 Expectoration

22(38.6)

3(13.6)

9(33.3)

4.565

0.102

 Chest pain

3(5.3)

1(4.5)

1(3.7)

0.289

0.999

 Headache

15(26.3)

10(45.5)

5(18.5)

4.574

0.112

 Dyspnea

6(10.5)

1(4.5)

4(14.8)

1.283

0.574

 Altered state of consciousness

1(1.8)

3(13.6)

2(7.4)

4.446

0.073

  1. Data presented as n of patients (%)